eClinicalMedicine General Medicine

Camrelizumab plus famitinib as first-line treatment for locally advanced or metastatic pulmonary sarcomatoid carcinomas (CAPSTONE): a multi-center, single-arm, phase 2 trial

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →